Abstract
Most malignant astrocytomas (gliomas) express a high level of Fas, whereas the surrounding normal tissues such as neurons and astrocytes express a very low level of Fas. Thus, transduction of Fas ligand would selectively kill malignant astrocytoma cells. On the other hand, glioma cells harboring p53 mutation have been reported to be resistant to conventional therapies including radiation. To override the resistance mechanism of glioma cells with p53 mutation to radiation, we transduced U‐373MG malignant astrocytoma (glioma) cells harboring mutant p53 with Fas ligand via an adenovirus (Adv) vector in combination with X‐ray irradiation, and evaluated the degree of apoptosis. The degree of apoptosis in U‐373MG cells infected with the Adv for Fas ligand (Adv‐FL) and treated with irradiation (81%) was much higher than that in U‐373MG cells infected with Adv‐FL and not treated with irradiation (0.8%) or that in U‐373MG cells infected with the control Adv for lacZ and treated with irradiation (5.0%). In U‐373MG cells infected with Adv‐FL, irradiation increased the expression of Fas ligand. Coincident with the increase in Fas ligand, there was a marked reduction in the caspase‐3 level and a marked increase in the cleaved form of poly(ADP‐ribose) polymerase (PARP), which are downstream components of Fas ligand‐mediated apoptosis. This suggests that the enhanced activation of caspase‐3 by the transduction of Fas ligand combined with irradiation, induced extensive apoptosis in U‐373MG cells. In summary, transduction of Fas ligand may override the resistance mechanism to radiotherapy in glioma cells harboring p53 mutation.
Keywords: Apoptosis, Radiation, Fas ligand, Glioma, Adenovirus
Full Text
The Full Text of this article is available as a PDF (231.1 KB).
REFERENCES
- 1. ) Clarke , A. R. , Purdie , C. A. , Harrison , D. J. , Morris , R. G. , Bird , C. C. , Hooper , M. L. and Wyllie , A. H.Thymocyte apoptosis induced by p53‐dependent and independent pathways . Nature , 362 , 849 – 852 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Lowe , S. W. , Schmitt , E. M. , Smith , S. W. , Osborne , B. A. and Jacks , T.p53 is required for radiation‐induced apoptosis in mouse thymocytes . Nature , 362 , 847 – 849 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Lee , J. U. , Hosotani , R. , Wada , M. , Doi , R. , Kosiba , T. , Fujimoto , K. , Miyamoto , Y. , Tsuji , S. , Nakajima , S. , Nishimura , Y. and Imamura , M.Role of Bcl‐2 family proteins (Bax, Bcl‐2 and Bcl‐X) on cellular susceptibility to radiation in pancreatic cancer cells . Eur. J. Cancer , 35 , 1374 – 1380 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Gjerset , R. A. , Turla , S. T. , Sobol , R. E. , Scalise , J. J. , Mercola , D. , Collins , H. and Hopkins , P. J.Use of wildtype p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53 . Mol. Carcinog. , 14 , 275 – 285 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Gallardo , D. , Drazan , K. E. and McBride , W. H.Adenovirus‐based transfer of wild‐type p53 gene increases ovarian tumor radiosensitivity . Cancer Res. , 56 , 4891 – 4893 ( 1996. ). [PubMed] [Google Scholar]
- 6. ) Sakakura , C. , Sweeney , E. A. , Shirahama , T. , Igarashi , Y. , Hakomori , S. , Nakatani , H. , Tsujimoto , H. , Imanishi , T. , Ohgaki , M. , Ohyama , T. , Yamazaki , J. , Hagiwara , A. , Yamaguchi , T. , Sawai , K. and Takahashi , T.Overexpression of bax sensitizes human breast cancer MCF‐7 cells to radiation‐induced apoptosis . Int. J. Cancer , 67 , 101 – 105 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Weller , M. , Frei , K. , Groscurth , P. , Krammer , P. H. , Yonekawa , Y. and Fontana , A.Anti‐Fas/APO‐1 antibodymediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines . J. Clin. Invest. , 94 , 954 – 964 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. ) Tachibana , O. , Nakazawa , H. , Lampe , J. , Watanabe , K. , Kleihues , P. and Ohgaki , H.Expression of Fas/APO‐1 during the progression of astrocytomas . Cancer Res. , 55 , 5528 – 5530 ( 1995. ). [PubMed] [Google Scholar]
- 9. ) Rensing‐Ehl , A. , Malipiero , U. , Irmler , M. , Tschopp , J. , Constam , D. and Fontana , A.Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO‐1/CD95) pathway . Eur. J. Cancer , 26 , 2271 – 2274 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Dowling , P. , Shang , G. , Raval , S. , Menonna , J. , Cook , S. and Husar , W.Involvement of the CD95 (APO‐1/Fas) receptor/ligand system in multiple sclerosis brain . J. Exp. Med. , 184 , 1513 – 1518 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. ) Shinoura , N. , Yoshida , Y. , Sadata , A. , Hanada , K. , Yamamoto , S. , Kirino , T. , Asai , A. and Hamada , H.Apoptosis by retrovirus‐ and adenovirus‐mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy . Hum. Gene Ther. , 9 , 1983 – 1993 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Enari , M. , Talanian , R. V. , Wong , W. W. and Nagata , S.Sequential activation of ICE‐like and CPP32‐like proteases during Fas‐mediated apoptosis . Nature , 380 , 723 – 726 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Fuchs , E. J. , McKenna , K. A. and Bedi , A.p53‐dependent DNA damage‐induced apoptosis requires Fas/APO‐1‐independent activation of CPP32beta . Cancer Res. , 57 , 2550 – 2554 ( 1997. ). [PubMed] [Google Scholar]
- 14. ) Yu , Y. and Little , J. B.p53 is involved in but not required for ionizing radiation‐induced caspase‐3 activation and apoptosis in human lymphoblast cell lines . Cancer Res. , 58 , 4277 – 4281 ( 1998. ). [PubMed] [Google Scholar]
- 15. ) Kanegae , Y. , Lee , G. , Sato , Y. , Tanaka , M. , Nakai , M. , Sakaki , T. , Sugano , S. and Saito , I.Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site‐specific Cre recombinase . Nucleic Acids Res. , 23 , 3816 – 3821 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. ) Shinoura , N. , Saito , K. , Yoshida , Y. , Hashimoto , M. , Asai , A. , Kirino , T. and Hamada , H.Adenovirus‐mediated transfer of Bax with caspase‐8 controlled by myelin basic protein promoter induces drastic apoptosis in gliomas . Cancer Gene Ther. , 7 , 739 – 748 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Miyake , S. , Makimura , M. , Kanegae , Y. , Harada , S. , Sato , Y. , Takamori , K. , Tokuda , C. and Saito , I.Efficient generation of recombinant adenoviruses using adenovirus DNAterminal protein complex and a cosmid bearing the fulllength virus genome . Proc. Natl. Acad. Sci. USA , 93 , 1320 – 1324 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. ) Yoshida , Y. and Hamada , H.Adenovirus‐mediated inducible gene expression through tetracycline‐controllable transactivator with nuclear localization signal . Biochem. Biophys. Res. Commun. , 230 , 426 – 430 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Fulda , S. , Scaffidi , C. , Pietsch , T. , Krammer , P. H. , Peter , M. E. and Debatin , K. M.Activation of the CD95 (APO‐1/ Fas) pathway in drug‐ and gamma‐irradiation‐induced apoptosis of brain tumor cells . Cell Death Differ. , 5 , 884 – 893 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 20. ) Shrieve , D. C. , Alexander , E. , 3rd , Black , P. M. , Wen , P. Y. , Fine , H. A. , Kooy , H. M. and Loeffler , J. S.Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long‐term outcome . J. Neurosurg. , 90 , 72 – 77 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Sarkaria , J. N. , Mehta , M. P. , Loeffler , J. S. , Buatti , J. M. , Chappell , R. J. , Levin , A. B. , Alexander , E. , 3rd , Friedman , W. A. and Kinsella , T. J.Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis . Int. J. Radiat. Oncol. Biol. Phys. , 32 , 931 – 941 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 22. ) Abdulkarim , B. , Sabri , S. , Deutsch , E. , Vaganay , S. , Marangoni , E. , Vainchenker , W. , Bongrand , P. , Busson , P. and Bourhis , J.Radiation‐induced expression of functional Fas ligand in EBV‐positive human nasopharyngeal carcinoma cells . Int. J. Cancer , 86 , 229 – 237 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 23. ) Villunger , A. , Egle , A. , Kos , M. , Hartmann , B. L. , Geley , S. , Kofler , R. and Greil , R.Drug‐induced apoptosis is associated with enhanced Fas (Apo‐1/CD95) ligand expression but occurs independently of Fas (Apo‐1/CD95) signaling in human T‐acute lymphatic leukemia cells . Cancer Res. , 57 , 3331 – 3334 ( 1997. ). [PubMed] [Google Scholar]
- 24. ) Herr , I. , Wilhelm , D. , Bohler , T. , Angel , P. and Debatin , K.‐B.Activation of CD95 (APO‐1/Fas) signaling by ceramide mediates cancer therapy‐induced apoptosis . EMBO J. , 16 , 6209 – 6216 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. ) Kitada , S. , Krajewski , S. , Miyashita , T. , Krajewska , M. and Reed , J. C.Gamma‐radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo . Oncogene , 12 , 187 – 192 ( 1996. ). [PubMed] [Google Scholar]
- 26. ) Hakem , R. , Hakem , A. , Duncan , G. S. , Henderson , J. T. , Woo , M. , Soengas , M. S. , Elia , A. , de la Pompa , J. L. , Kagi , D. , Khoo , W. , Potter , J. , Yoshida , R. , Kaufman , S. A. , Lowe , S. A. , Penninger , J. M. and Mak , T. W.Differential requirement for caspase‐9 in apoptotic pathways in vivo . Cell , 94 , 339 – 352 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 27. ) Newton , K. and Strasser , A.Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy . J. Exp. Med. , 191 , 195 – 200 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. ) Datta , R. , Kojima , H. , Banach , D. , Bump , N. J. , Talanian , R. V. , Alnemri , E. S. , Weichselbaum , R. R. , Wong , W. W. and Kufe , D. W.Activation of a CrmA‐insensitive, p35‐ sensitive pathway in ionizing radiation‐induced apoptosis . J. Biol. Chem. , 272 , 1965 – 1969 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 29. ) Tepper , A. D. , de Vries , E. , van Blitterswijk , W. J. and Borst , J.Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95‐ and DNA damageinduced apoptosis . J. Clin. Invest. , 103 , 971 – 978 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. ) Boesen‐de Cock , J. G. , Tepper , A. D. , de Vries , E. , van Blitterswijk , W. J. and Borst , J.Common regulation of apoptosis signaling induced by CD95 and the DNA‐damaging stimuli etoposide and gamma‐radiation downstream from caspase‐8 activation . J. Biol. Chem. , 274 , 14255 – 14261 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 31. ) Kataoka , T. , Schroter , M. , Hahne , M. , Schneider , P. , Irmler , M. , Thome , M. , Froelich , C. J. and Tschopp , J.FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation . J. Immunol. , 161 , 3936 – 3942 ( 1998. ). [PubMed] [Google Scholar]
- 32. ) Zhao , Q. L. , Kondo , T. , Noda , A. and Fujiwara , Y.Mitochondrial and intracellular free‐calcium regulation of radiation‐induced apoptosis in human leukemic cells . Int. J. Radiat. Biol. , 75 , 493 – 504 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 33. ) Yount , G. L. , Levine , K. S. , Kuriyama , H. , Haas‐Kogan , D. A. and Israel , M. A.Fas (APO‐1/CD95) signaling pathway is intact in radioresistant human glioma cells . Cancer Res. , 59 , 1362 – 1365 ( 1999. ). [PubMed] [Google Scholar]
- 34. ) Shinoura , N. , Ohashi , M. , Yoshida , Y. , Kirino , T. , Asai , A. , Hashimoto , M. and Hamada , H.Adenovirus‐mediated overexpression of Fas induces apoptosis in gliomas . Cancer Gene Ther. , 7 , 224 – 232 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 35. ) Saas , P. , Walker , P. R. , Hahne , M. , Quiquerez , A. L. , Schnuriger , V. , Perrin , G. , French , L. , Van Meir , E. G. , de Tribolet , N. , Tschopp , J. and Dietrich , P. Y.Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain ? J. Clin. Invest. , 99 , 1173 – 1178 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. ) Gratas , C. , Tohma , Y. , Van Meir , E. G. , Klein , M. , Tenan , M. , Ishii , N. , Tachibana , O. , Kleihues , P. and Ohgaki , H.Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors . Brain Pathol. , 7 , 863 – 869 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. ) Husain , N. , Chiocca , E. A. , Rainov , N. , Louis , D. N. and Zervas , N. T.Co‐expression of Fas and Fas ligand in malignant glial tumors and cell lines . Acta Neuropathol. (Berl.) , 95 , 287 – 290 ( 1998. ). [DOI] [PubMed] [Google Scholar]